Do patients with axial spondyloarthritis with active disease suffer from greater disease burden and work impairment? Results from the International Map of Axial Spondyloarthritis (IMAS)

Garrido-Cumbrera, Marco, Poddubnyy, Denis, Sommerfleck, Fernando, Bundy, Christine ORCID: https://orcid.org/0000-0002-5981-3984, Makri, Souzi, Correa-Fernández, José, Akerkar, Shashank, Lowe, Jo, Karam, Elie and Navarro-Compán, Victoria 2024. Do patients with axial spondyloarthritis with active disease suffer from greater disease burden and work impairment? Results from the International Map of Axial Spondyloarthritis (IMAS). Reumatología Clínica (English Edition) 20 (10) , pp. 547-554. 10.1016/j.reumae.2024.11.009

Preview

PDF - Published Version Available under License Creative Commons Attribution. Download (698kB) | Preview

Abstract

Background: To assess the prevalence of clinically active disease in axial spondyloarthritis (axSpA) and its associated factors in a large global sample of patients from the International Map of Axial Spondyloarthritis (IMAS) study. Methods: IMAS is a cross-sectional online survey (2017–2022) of 5557 axSpA patients. Patients were divided between those with active disease (BASDAI ≥4) and without active disease (BASDAI <4). The factors evaluated were sociodemographic, lifestyle, patient-reported outcomes, employment, disease characteristics, extra-musculoskeletal manifestations, and treatment. Logistic regression analysis stratified by gender were used to evaluate the relationship between investigated factors and active disease. Results: In the present study, 5295 patients who had responded to the BASDAI scale were included in the present study: 3231 were from Europe, 770 from North America, 600 from Asia, 548 from Latin America, and 146 from Africa. The mean age was 43.8 ± 12.9 years and 55.4% were females. Patients reported a mean BASDAI of 5.4 (±2.1) with 75% having active disease (BASDAI ≥4). In South Africa, 87.0% of patients reported having active disease, compared to 68.5% in Asia. Multivariable logistic regression showed an association of active disease with higher functional limitation, greater spinal stiffness, difficulty finding a job due to axSpA and worse mental health in both genders. For males, younger age and shorter diagnostic delay, and for females, no physical activity and presence of inflammatory bowel disease were associated with active disease. Conclusions: Three quarters of patients with axSpA reported clinically active disease, with higher proportion of patients with active disease in South Africa and lower proportion in Asia. Our results underline the complexity of the clinical disease activity concept in axSpA and the need for a holistic approach in the patient management, care and treatment.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Healthcare Sciences
Publisher:	Elsevier
ISSN:	2173-5743
Date of First Compliant Deposit:	10 December 2024
Date of Acceptance:	3 October 2024
Last Modified:	11 Dec 2024 10:46
URI:	https://orca.cardiff.ac.uk/id/eprint/174637

Actions (repository staff only)

Edit Item